The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Ariela Benigni

Mario Negri Institute for Pharmacological Research

Via Gavazzeni 11




Name/email consistency: high



  • Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, Bergamo, Italy. 2001 - 2009


  1. Disruption of the Ang II type 1 receptor promotes longevity in mice. Benigni, A., Corna, D., Zoja, C., Sonzogni, A., Latini, R., Salio, M., Conti, S., Rottoli, D., Longaretti, L., Cassis, P., Morigi, M., Coffman, T.M., Remuzzi, G. J. Clin. Invest. (2009) [Pubmed]
  2. Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. Benigni, A., Caroli, C., Longaretti, L., Gagliardini, E., Zoja, C., Galbusera, M., Moioli, D., Romagnani, P., Tincani, A., Andreoli, L., Remuzzi, G. Arthritis Rheum. (2007) [Pubmed]
  3. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone. Benigni, A., Zoja, C., Tomasoni, S., Campana, M., Corna, D., Zanchi, C., Gagliardini, E., Garofano, E., Rottoli, D., Ito, T., Remuzzi, G. J. Am. Soc. Nephrol. (2006) [Pubmed]
  4. Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started. Benigni, A., Zoja, C., Campana, M., Corna, D., Sangalli, F., Rottoli, D., Gagliardini, E., Conti, S., Ledbetter, S., Remuzzi, G. Nephron Exp. Nephrol. (2006) [Pubmed]
  5. Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria. Benigni, A., Corna, D., Zoja, C., Longaretti, L., Gagliardini, E., Perico, N., Coffman, T.M., Remuzzi, G. J. Am. Soc. Nephrol. (2004) [Pubmed]
  6. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy. Benigni, A., Zoja, C., Zatelli, C., Corna, D., Longaretti, L., Rottoli, D., Maggioni, P., Todeschini, M., Noris, M., Remuzzi, G. Kidney Int. (2004) [Pubmed]
  7. The potential of endothelin antagonism as a therapeutic approach. Benigni, A., Perico, N., Remuzzi, G. Expert. Opin. Investig. Drugs (2004) [Pubmed]
  8. Impediments to successful gene transfer to the kidney in the context of transplantation and how to overcome them. Benigni, A., Tomasoni, S., Remuzzi, G. Kidney Int. (2002) [Pubmed]
  9. Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression. Benigni, A., Perico, N., Remuzzi, G. Curr. Opin. Nephrol. Hypertens. (2001) [Pubmed]
  10. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. Benigni, A., Tomasoni, S., Gagliardini, E., Zoja, C., Grunkemeyer, J.A., Kalluri, R., Remuzzi, G. J. Am. Soc. Nephrol. (2001) [Pubmed]
WikiGenes - Universities